Wells Fargo Maintains Overweight on Insulet, Lowers Price Target to $330
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Lawrence Biegelsen has maintained an Overweight rating on Insulet (NASDAQ:PODD) but lowered the price target from $375 to $330.
August 09, 2023 | 3:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Insulet's price target has been lowered by Wells Fargo from $375 to $330, though the Overweight rating is maintained.
The lowering of the price target by a major financial institution like Wells Fargo could potentially lead to a decrease in the stock price of Insulet in the short term. However, the maintained Overweight rating indicates that the stock is still expected to outperform.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100